{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:04:09Z","timestamp":1751000649073,"version":"3.41.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The authors present the case of a 34-year-old male patient who underwent therapeutic plasma exchange (TPE) for amyopathic dermatomyositis. Immunosuppression resulted in <jats:italic toggle=\"yes\">Aspergillus lentulus<\/jats:italic> pulmonary infection<jats:italic toggle=\"yes\">,<\/jats:italic> requiring treatment with super bioavailable-itraconazole. Therapeutic itraconazole concentrations were attained after 2 weeks of treatment after dose adjustments. Interestingly, a substantial reduction in plasma itraconazole concentration was observed during TPE, which was attributed to an insufficient delay between the dosing of itraconazole and TPE initiation. Furthermore, there was an increase in plasma concentration post-TPE, which presumably reflects the redistribution of itraconazole from peripheral compartments back into plasma. This was confirmed by sampling of the TPE plasmapheresate, which revealed that changes in plasma concentration overestimated itraconazole clearance. These findings highlight that the pharmacokinetics of itraconazole are altered during TPE, which should be considered when timing drug administration and obtaining plasma concentrations.<\/jats:p>","DOI":"10.1097\/ftd.0000000000001057","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T23:33:53Z","timestamp":1675380833000},"page":"129-132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Effect of Therapeutic Plasma Exchange on Itraconazole Pharmacokinetics: A Case Study"],"prefix":"10.1097","volume":"45","author":[{"given":"Vincent","family":"Seah","sequence":"first","affiliation":[{"name":"St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney;"},{"name":"Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital, Sydney;"},{"name":"Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thulashigan","family":"Sreeharan","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney;"},{"name":"Sydney School of Pharmacy, The University of Sydney, Sydney;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Kocic","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney;"},{"name":"Department of Chemical Pathology and Clinical Pharmacology, SydPath, St Vincent's Hospital, Sydney;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"Reuter","sequence":"additional","affiliation":[{"name":"UniSA Clinical and Health Sciences, University of South Australia, Adelaide; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila","family":"Girgis","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent's Hospital, Sydney, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah J. E.","family":"Marriott","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney;"},{"name":"Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital, Sydney;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-587X","authenticated-orcid":false,"given":"Sophie L.","family":"Stocker","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney;"},{"name":"Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney;"},{"name":"Sydney School of Pharmacy, The University of Sydney, Sydney;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/rheumatology\/kez357","article-title":"Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy","volume":"59","author":"Abe","year":"2020","journal-title":"Rheumatology"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1093\/rheumatology\/keaa123","article-title":"Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment","volume":"59","author":"Shirakashi","year":"2020","journal-title":"Rheumatology"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ajcp\/aqx056","article-title":"Therapeutic plasma exchange and its impact on drug levels: an ACLPS critical review","volume":"148","author":"Cheng","year":"2017","journal-title":"Am J Clin Pathol."},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/pharmaceutics12050395","article-title":"Is antimicrobial treatment effective during therapeutic plasma exchange? Investigating the role of possible interactions","volume":"12","author":"Krzych","year":"2020","journal-title":"Pharmaceutics"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2710.2008.00964.x","article-title":"Amphotericin B removal by plasma exchange","volume":"34","author":"Lew","year":"2009","journal-title":"J Clin Pharm Ther."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1744-9987.2009.00797.x","article-title":"Impact of plasma exchange on pharmacokinetic disposition of micafungin","volume":"14","author":"Konishi","year":"2010","journal-title":"Ther Apher Dial."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/jac\/dki220","article-title":"Making sense of itraconazole pharmacokinetics","volume":"56","author":"Prentice","year":"2005","journal-title":"J Antimicrob Chemother."},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1592\/phco.27.11.1529","article-title":"Drug removal by plasmapheresis: an evidence-based review","volume":"27","author":"Ibrahim","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1128\/AAC.00973-15","article-title":"Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and SPORANOX capsule formulations in healthy subjects in fed and fasted states","volume":"59","author":"Abuhelwa","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"R12-20250603","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000952","article-title":"Antifungal drugs TDM: trends and update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther Drug Monit."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:22:57Z","timestamp":1748971377000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001057","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}